Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.
Houston—More than 12 million people in the United States and European Union have congestive heart failure, but there are only about 4,500 hearts available each year for transplant.
LVADs—left ventricular assist devices—have been used to help some of these patients, but installing them means cracking open patients’ chests in expensive open-heart surgery and a month-long recovery time. The devices are also not suited for small people or for those who are already frail. And in up to about 11 percent of those who receive them, the devices can cause strokes.
